Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
HIST1H1T - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SHC3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TGM2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RARS2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HCK - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LOC647070 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors
CACNB4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MED28 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LRRC14 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TBL1Y - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ARHGAP6 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ACSBG1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TRIM29 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
THPO - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CACNA1D - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ADIRF - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
COL1A1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ETS2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
POSTN - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GRM5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on